Adcomm vote 10 to 3 to approve for ARCX this afternoon. PDUFA date Nov. 2 for them I think. If you can get in early Monday it could be a good score. Long term, a great score. IV morphine alternative for ER and post surgery situations. Opioid, so it needs to be tightly controlled in the current US situation. There is a morphine shortage right now, plus it does not have the overhead cost of an IV. Also already EU approved, like Cytosorb, so FDA approval could instantly boost sales overseas.